IMMUNOHISTOCHEMICAL PROFILING OF ADVANCED-STAGE OVARIAN CANCER WITH PERITONEAL CARCINOMATOSIS

Authors

  • Esankulova B. S. Author
  • Nasullayeva M. M. Samarkand State Medical University Author

Keywords:

Ovarian cancer, immunohistochemistry, peritoneal carcinomatosis, biomarkers, prognosis, targeted therapy.

Abstract

Ovarian cancer remains a leading cause of gynecological cancer-related mortality, with advanced-stage disease (Stage III-IV) often presenting with peritoneal carcinomatosis. Immunohistochemistry (IHC) plays a critical role in characterizing tumor subtypes, guiding treatment decisions, and predicting patient outcomes. This article reviews the current understanding of IHC markers used in ovarian cancer, their prognostic significance, and implications for targeted therapies.

Downloads

Published

2025-01-29

Issue

2025: ICNCS- JAN

Section

Articles

How to Cite

IMMUNOHISTOCHEMICAL PROFILING OF ADVANCED-STAGE OVARIAN CANCER WITH PERITONEAL CARCINOMATOSIS. (2025). International Conference on Scientific Research in Natural and Social Sciences, 189-191. https://econfseries.com/index.php/1/article/view/591